Marcus J Schultz and Prashant Nasa on defining and subphenotyping ARDS

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/c1/6d/67/c16d67ee-75bb-6bc4-4913-bb82f8f0987b/mza_10328428802757500552.jpg/600x600bb.jpg

The Lancet Respiratory Medicine in conversation with

The Lancet Group

57 episodes

1 day ago

Dr Finn McQuaid and Dr Matthew Saunders join Arianna Colosio to discuss an analytical framework to describe potential causal relationships between climate change and tuberculosis. Click here to read the full article Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

All content for The Lancet Respiratory Medicine in conversation with is the property of The Lancet Group and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Marcus J Schultz and Prashant Nasa on defining and subphenotyping ARDS

The Lancet Respiratory Medicine in conversation with

11 minutes

5 months ago

Marcus J Schultz and Prashant Nasa on defining and subphenotyping ARDS

Bianca Brandon is joined by Professor Marcus Schultz and Dr Prashant Nasa to discuss their recent Position Paper reporting insights from an international Delphi expert panel on defining and subphenotyping ARDS. The findings underscore the need to refine the ARDS definition to better address heterogeneity of the condition and improve diagnostic precision, with use of subphenotyping where appropriate. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)0011...